The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Associations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults
Open accessAbstract
Many studies suggest that trimethylamine-N-oxide (TMAO), a gut-flora-dependent metabolite of choline, contributes to the risk of cardiovascular diseases, but little is known for non-alcoholic fatty liver disease (NAFLD). We examined the association of circulating TMAO, choline and betaine with the presence and severity of NAFLD in Chinese adults. We performed a hospital-based case-control study (CCS) and a cross-sectional study (CSS). In the CCS, we recruited 60 biopsy-proven NAFLD cases and 35 controls (18–60 years) and determined serum concentrations of TMAO, choline and betaine by HPLC-MS/MS. For the CSS, 1,628 community-based adults (40-75 years) completed the blood tests and ultrasonographic NAFLD evaluation. In the CCS, analyses of covariance showed adverse associations of ln-transformed serum levels of TMAO, choline and betaine/choline ratio with the scores of steatosis and total NAFLD activity (NAS) (all P-trend <0.05). The CSS revealed that a greater severity of NAFLD was independently correlated with higher TMAO but lower betaine and betaine/choline ratio (all P-trend <0.05). No significant choline-NAFLD association was observed. Our findings showed adverse associations between the circulating TMAO level and the presence and severity of NAFLD in hospital- and community-based Chinese adults and a favorable betaine-NAFLD relationship in the community-based participants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Self-citationGut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
Koeth, R. A., Wang, Z., Levison, B. S., Buffa, J. A., Org, E., Sheehy, B. T., Britt, E. B., Fu, X., Wu, Y., Li, L., et al. (2013) · Nature Medicine · doi:10.1038/nm.3145 · Cited by 4,386
Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Hepatology · doi:10.1002/hep.25762 · Cited by 3,803
Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk
Tang, W. H. W., Wang, Z., Levison, B. S., Koeth, R. A., Britt, E. B., Fu, X., Wu, Y., & Hazen, S. L. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1109400 · Cited by 3,400
Hernaez, R., Lazo, M., Bonekamp, S., Kamel, I., Brancati, F. L., Guallar, E., & Clark, J. M. (2011) · Hepatology · doi:10.1002/hep.24452 · Cited by 1,585
Tang, W. H. W., Wang, Z., Kennedy, D. J., Wu, Y., Buffa, J. A., Agatisa-Boyle, B., Li, X. S., Levison, B. S., & Hazen, S. L. (2015) · Circulation Research · doi:10.1161/circresaha.116.305360 · Cited by 1,223
(2017) · Arzneimittelforschung · doi:10.1055/s-00000175 · Cited by 1,134
Bennett, B. J., Vallim, T. Q. D. A., Wang, Z., Shih, D. M., Meng, Y., Gregory, J., Allayee, H., Lee, R., Graham, M., Crooke, R., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2012.12.011 · Cited by 1,070
Dumas, M.-E., Barton, R. H., Toye, A., Cloarec, O., Blancher, C., Rothwell, A., Fearnside, J., Tatoud, R., Blanc, V., Lindon, J. C., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601056103 · Cited by 1,042
Endpoints and clinical trial design for nonalcoholic steatohepatitis
Sanyal, A. J., Brunt, E. M., Kleiner, D. E., Kowdley, K. V., Chalasani, N., Lavine, J. E., Ratziu, V., & McCullough, A. (2011) · Hepatology · doi:10.1002/hep.24376 · Cited by 750
Tang, W. H. W., Wang, Z., Fan, Y., Levison, B., Hazen, J. E., Donahue, L. M., Wu, Y., & Hazen, S. L. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.617 · Cited by 681
Choline and betaine in health and disease
Ueland, P. M. (2011) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9088-4 · Cited by 576
Wang, Z., Tang, W. H. W., Buffa, J. A., Fu, X., Britt, E. B., Koeth, R. A., Levison, B. S., Fan, Y., Wu, Y., & Hazen, S. L. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu002 · Cited by 559
Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression
Corbin, K. D., & Zeisel, S. H. (2012) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32834e7b4b · Cited by 502
Trøseid, M., Ueland, T., Hov, J. R., Svardal, A., Gregersen, I., Dahl, C. P., Aakhus, S., Gude, E., Bjørndal, B., Halvorsen, B., et al. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12328 · Cited by 464
NAFLD in Asia—as common and important as in the West
Farrell, G. C., Wong, V. W.-S., & Chitturi, S. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.34 · Cited by 432
Dietary trimethylamine N-oxide exacerbates impaired glucose tolerance in mice fed a high fat diet
Gao, X., Liu, X., Xu, J., Xue, C., Xue, Y., & Wang, Y. (2014) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2014.03.001 · Cited by 360
Buchman, A. L., Dubin, M. D., Moukarzel, A. A., Jenden, D. J., Roch, M., Rice, K. M., Gornbein, J., & Ament, M. E. (1995) · Hepatology · doi:10.1002/hep.1840220510 · Cited by 327
Chen, C.-H., Huang, M.-H., Yang, J.-C., Nien, C.-K., Yang, C.-C., Yeh, Y.-H., & Yueh, S.-K. (2006) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200609000-00016 · Cited by 294
Epidemiology of alcoholic and nonalcoholic fatty liver disease in China
Fan, J. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12036 · Cited by 247
Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases*
ZENG, M. D., FAN, J. G., LU, L. G., LI, Y. M., CHEN, C. W., WANG, B. Y., & MAO, Y. M. (2008) · Journal of Digestive Diseases · doi:10.1111/j.1751-2980.2008.00331.x · Cited by 242
Konstantinova, S. V., Tell, G. S., Vollset, S. E., Nygård, O., Bleie, Ø., & Ueland, P. M. (2008) · The Journal of Nutrition · doi:10.1093/jn/138.5.914 · Cited by 240
Bril, F., Ortiz‐Lopez, C., Lomonaco, R., Orsak, B., Freckleton, M., Chintapalli, K., Hardies, J., Lai, S., Solano, F., Tio, F., et al. (2015) · Liver International · doi:10.1111/liv.12840 · Cited by 237
Betaine for nonalcoholic fatty liver disease: Results of a randomized placebo‐controlled trial†
Abdelmalek, M. F., Sanderson, S. O., Angulo, P., Soldevila‐Pico, C., Liu, C., Peter, J., Keach, J., Cave, M., Chen, T., McClain, C. J., et al. (2009) · Hepatology · doi:10.1002/hep.23239 · Cited by 225
Lever, M., George, P. M., Slow, S., Bellamy, D., Young, J. M., Ho, M., McEntyre, C. J., Elmslie, J. L., Atkinson, W., Molyneux, S. L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114969 · Cited by 223
Kharbanda, K. K., Mailliard, M. E., Baldwin, C. R., Beckenhauer, H. C., Sorrell, M. F., & Tuma, D. J. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2006.08.024 · Cited by 200
Noga, A. A., & Vance, D. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301982200 · Cited by 197
Raubenheimer, P. J., Nyirenda, M. J., & Walker, B. R. (2006) · Diabetes · doi:10.2337/db06-0097 · Cited by 197
Role of diet and nutritional management in non‐alcoholic fatty liver disease
Fan, J., & Cao, H. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12244 · Cited by 191
GRAIF, M., YANUKA, M., BARAZ, M., BLANK, A., MOSHKOVITZ, M., KESSLER, A., GILAT, T., WEISS, J., WALACH, E., AMAZEEN, P., et al. (2000) · Investigative Radiology · doi:10.1097/00004424-200005000-00006 · Cited by 182
[Guidelines for diagnosis and treatment of nonalcoholic fatty liver diseases].
(2006) · PubMed · Cited by 167
Choline intake in a large cohort of patients with nonalcoholic fatty liver disease
Guerrerio, A. L., Colvin, R. M., Schwartz, A. K., Molleston, J. P., Murray, K. F., Diehl, A., Mohan, P., Schwimmer, J. B., Lavine, J. E., Torbenson, M. S., et al. (2012) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.020156 · Cited by 140
Wang, L.-J., Zhang, H.-W., Zhou, J.-Y., Liu, Y., Yang, Y., Chen, X.-L., Zhu, C.-H., Zheng, R.-D., Ling, W., & Zhu, H.-L. (2014) · Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.11.007 · Cited by 122
Self-citationEfficacy and Safety of Oral Betaine Glucuronate in Non-alcoholic Steatohepatitis
Miglio, F., Rovati, L. C., Santoro, A., & Setnikar, I. (2011) · Arzneimittelforschung · doi:10.1055/s-0031-1300279 · Cited by 106
Deminice, R., da Silva, R. P., Lamarre, S. G., Kelly, K. B., Jacobs, R. L., Brosnan, M. E., & Brosnan, J. T. (2015) · Amino Acids · doi:10.1007/s00726-014-1913-x · Cited by 94
Yu, D., Shu, X., Xiang, Y., Li, H., Yang, G., Gao, Y., Zheng, W., & Zhang, X. (2014) · Journal of Nutrition · doi:10.3945/jn.114.197533 · Cited by 79
Dilger, R. N., Garrow, T. A., & Baker, D. H. (2007) · Journal of Nutrition · doi:10.1093/jn/137.10.2224 · Cited by 77
Huang, B., Zhu, M.-F., Wu, T., Zhou, J.-Y., Liu, Y., Chen, X., Zhou, R.-F., Wang, L., Chen, Y., & Zhu, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118071 · Cited by 66
Self-citationDanne, O., Lueders, C., Storm, C., Frei, U. A., & Möckel, M. M. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.05.001 · Cited by 57
Chen, Y.-M., LIU, Y.-Y., Liu, Y.-H., Wang, X., Guan, K., & Zhu, H.-L. (2014) · International Journal of Obesity · doi:10.1038/ijo.2014.158 · Cited by 57
Self-citationImajo, K., Fujita, K., Yoneda, M., Shinohara, Y., Suzuki, K., Mawatari, H., Takahashi, J., Nozaki, Y., Sumida, Y., Kirikoshi, H., et al. (2012) · Hepatology Research · doi:10.1111/j.1872-034x.2012.00976.x · Cited by 40
Wallace, J. M. W., McCormack, J. M., McNulty, H., Walsh, P. M., Robson, P. J., Bonham, M. P., Duffy, M. E., Ward, M., Molloy, A. M., Scott, J. M., et al. (2011) · British Journal Of Nutrition · doi:10.1017/s000711451100674x · Cited by 36
Effects of Dietary Supplementation with Betaine on a Nonalcoholic Steatohepatitis (NASH) Mouse Model
Kawakami, S., Han, K., Nakamura, Y., Shimada, K., KITANO, T., Aritsuka, T., Nagura, T., Ohba, K., Nakamura, K., & Fukushima, M. (2012) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.58.371 · Cited by 32
Cited by
The gut-liver axis in liver disease: Pathophysiological basis for therapy
Albillos, A., de Gottardi, A., & Rescigno, M. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.10.003 · Cited by 2,166
The gut-liver axis and the intersection with the microbiome
Tripathi, A., Debelius, J., Brenner, D. A., Karin, M., Loomba, R., Schnabl, B., & Knight, R. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0011-z · Cited by 1,480
Loomba, R., Seguritan, V., Li, W., Long, T., Klitgord, N., Bhatt, A., Dulai, P. S., Caussy, C., Bettencourt, R., Highlander, S. K., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.04.001 · Cited by 1,123
The intestinal microbiota fuelling metabolic inflammation
Tilg, H., Zmora, N., Adolph, T. E., & Elinav, E. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0198-4 · Cited by 1,089
Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
Aron-Wisnewsky, J., Vigliotti, C., Witjes, J., Le, P., Holleboom, A. G., Verheij, J., Nieuwdorp, M., & Clément, K. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0269-9 · Cited by 1,063
Metadata
- Authors
- Chen, Y.-M., Liu, Y., Zhou, R.-F., Chen, X.-L., Wang, C., Tan, X.-Y., Wang, L.-J., Zheng, R.-D., Zhang, H.-W., Ling, W.-H., & Zhu, H.-L.
- Venue
- Scientific Reports
- Published
- 2016-01-08
- Volume
- 6
- Issue
- 1
- Pages
- 19076-19076
- ISSN
- 2045-2322 (ISSN-L)
- OpenAlex
- W2230400342
- Cited by
- 358
- References
- 44
- FWCI
- 20.99
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.